Summary: Tapering Guidelines and Addiction Risks
A medically researched guide on which Bipolar medications are physically addictive and why none of them should ever be stopped abruptly.
Escitalopram: Side Effects, Weight Gain, and Black Box Warnings (Part 2)
A detailed breakdown of Escitalopram's side effects, including the FDA black box warning for suicidality, the risk of a manic switch, and weight changes.
Lorazepam: Side Effects, Addiction Risks, and Black Box Warnings (Part 2)
A detailed breakdown of Lorazepam's severe side effects, including the FDA black box warning for respiratory depression, the risk of physical addiction, and weight changes.
Olanzapine: Side Effects, Weight Gain, and Black Box Warnings (Part 2)
A detailed breakdown of Olanzapine's side effects, focusing on massive weight gain, metabolic syndrome, tardive dyskinesia, and FDA black box warnings.
Propranolol: Side Effects, Asthma Risks, and Rebound Hypertension (Part 2)
A detailed breakdown of Propranolol's side effects, focusing on its cardiovascular impact, weight changes, the absolute danger for asthmatics, and rebound hypertension.
Sodium Valproate: Side Effects, Weight Gain, and Warnings (Part 2)
A detailed breakdown of Sodium Valproate's side effects, including heavy weight gain, FDA black box warnings, teratogenicity, and signs of overdose.
Summary: The Most Dangerous Drug Interactions
A quick-reference guide to the lethal drug and alcohol combinations that must be avoided when taking Bipolar Disorder medications.
Summary: Liver, Kidney, and Organ Toxicity
A comparison of the internal organ toxicity risks of Bipolar medications, focusing on Sodium Valproate's hepatotoxicity and Olanzapine's metabolic impact.